Hims Faces Historic Decline as Amazon Enters Hair Loss Drug Arena

In a significant market shake-up, Hims & Hers Health Inc. experienced its steepest drop in stock price to date, plummeting by over 30% following the announcement that Amazon is venturing into the hair loss treatment market. This news sent shockwaves through the health and wellness sector, particularly affecting companies that have built their business models around telehealth and direct-to-consumer pharmaceuticals.

Continue reading